Mucosal Vaccines

Friday, July 17, 2015: 10:30 AM-11:45 AM

Hall Berlin C, Ground Floor (Maritim Hotel)

10:30 AM

Chair

10:45 AM

OR.73

Mucosal Immune Responses Following Radio Controlled Capsule Delivery to Human Intestines - An Open Label Clinical Trial of An Influenza Vaccine Based on Recombinant Adenovirus
Sean Tucker, Vaxart; David Liebowitz, MD, PhD, Vaxart; Erik Sandefer, PhD, Scintipharma; Walter Doll, MD, PhD, Scintipharma; Leesun Kim, PhD, Vaxart

11:00 AM

OR.74

Lymphotoxin Signaling is Essential in the Generation of Protective Responses to Mucosal Vaccines
Joanna Wroblewska, University of Chicago; Yuan Zhang, University of Chicago; Yang-Xin Fu, University of Chicago

11:15 AM

OR.75

Long-Lived T_RM Th17 Cells Develop After Bacterial Immunization
Maria Amezcua Vesely, PhD, Yale University; Nicola Gagliani, PhD, Yale University; Paula Licona-Limon, PhD, Yale University; Hao Xu, Student, Yale University; Richard Flavell, PhD, Yale University

11:30 AM

OR.76

Nasal Vaccination Induces Innate Lymphoid Cells (ILC1s) and NK Cells to Initiate the Lung IFN-γ Cascade That Supports Adaptive T Cells Responses to Brucella
David W. Pascual, Ph.D., University of Florida; Hongbin Wang, University of Florida; Xinghong Yang, Ph.D., University of Florida; Beata Clapp, D.V.M., Ph.D., University of Florida

See more of: Oral Abstract Sessions

<< Previous Session | Next Session >>